These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 30959)

  • 1. [Study of pindolol given once daily in a dose of 15 mg in arterial hypertension].
    Barraine R; Bouchez C
    Nouv Presse Med; 1978 Sep; 7(31):2765-6. PubMed ID: 30959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Single daily dose of pindolol in the treatment of arterial hypertension].
    Ciaramelli F
    Nouv Presse Med; 1978 Sep; 7(31):2761-4. PubMed ID: 30958
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of a single oral dose of pindolol].
    Safar M; Weiss Y; Milliez P
    Nouv Presse Med; 1978 Sep; 7(31):2767-8. PubMed ID: 30960
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of 'responders' to long-term pindolol therapy from phasic changes in cardiovascular function during acute intravenous administration in essential hypertension.
    Logan AG; Milne BJ; Colman JM
    Clin Invest Med; 1978; 1(3-4):147-52. PubMed ID: 42504
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term utilization of beta-blockers in arterial hypertension].
    Tannenbaum H
    Nouv Presse Med; 1978 Sep; 7(31):2789-94. PubMed ID: 30966
    [No Abstract]   [Full Text] [Related]  

  • 6. [Place of beta-blockers in the treatment of essential arterial hypertension].
    Dallocchio M; Clémenty J; Dany F
    Nouv Presse Med; 1978 Sep; 7(31):2785-8. PubMed ID: 30965
    [No Abstract]   [Full Text] [Related]  

  • 7. [Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
    Torres Zamora M
    Prensa Med Mex; 1977; 42(3-4):127-32. PubMed ID: 917991
    [No Abstract]   [Full Text] [Related]  

  • 8. [Utilization of pindolol in arterial hypertension. Study during rest and during effort].
    Tassy J; Jouve A
    Nouv Presse Med; 1978 Sep; 7(31):2783-4. PubMed ID: 30964
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of LB 46 on the blood pressure in essential hypertension.
    Duner H
    Indian Heart J; 1972 Jun; 24():Suppl 1:236-7. PubMed ID: 4147279
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term blood pressure control with pindolol given once daily.
    Frithz G; Danielson M; Henningsen N; Malmborg RO; Nordström-Ohrberg G; Schröder G
    Eur J Cardiol; 1978; 7(2-3):131-6. PubMed ID: 27369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effect of bopindolol: a multi-centre study.
    Török E; Szám I; Buday G; Kerkovits G; Farsang C; Hajtman B
    J Hum Hypertens; 1990 Aug; 4(4):458-60. PubMed ID: 1979635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 14. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
    Hartikainen M; Heikkilä J
    Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.
    Spieker C; Vetter W; Zidek W; Vetter H
    Arzneimittelforschung; 1989 Nov; 39(11A):1512-4. PubMed ID: 2576202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pindolol in hypertension: twice-daily versus thrice-daily dosage.
    Waal-Manning HJ; Wood AJ
    Med J Aust; 1975 Aug; 2(7):274-5. PubMed ID: 1160793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacodynamic effects of the beta-blocker mepindolol administered transdermally to healthy volunteers].
    Liedtke RK
    Schweiz Rundsch Med Prax; 1987 Jul; 76(30-31):854-6. PubMed ID: 2889251
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of mepindolol sulphate.
    Bonelli J; Hitzenberger G; Krause W; Wendt H; Speck U
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):169-76. PubMed ID: 6103882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive activity of a new vasodilator, cadralazine, administered alone or in combination with a beta-blocker.
    Buoninconti R; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):613-6. PubMed ID: 2867048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily pindolol in hypertension: an ambulatory assessment.
    Raftery EB; Mann S; BalaSubramanian V; Craig MW
    Am Heart J; 1982 Aug; 104(2 Pt 2):417-20. PubMed ID: 7102527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.